| [1] |
Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases[J]. Nat Rev Drug Discov, 2012, 11(9): 709-730.
|
| [2] |
Jiang P, Mizushima N. Autophagy and human diseases[J]. Cell Res, 2014, 24(1): 69-79.
|
| [3] |
Debnath J. The multifaceted roles of autophagy in tumors-implications for breast cancer[J]. J Mammary Gland Biol Neoplasia, 2011, 16(3): 173-187.
|
| [4] |
White E. Deconvoluting the context-dependent role for autophagy in cancer[J]. Nat Rev Cancer, 2012, 12(6): 401-410.
|
| [5] |
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
|
| [6] |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-386.
|
| [7] |
Hudis CA, Gianni L. Triple-negative breast cancer: an unmet medical need[J]. Oncologist, 2011, 16 Suppl 1: 1-11.
|
| [8] |
Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours[J]. Nature, 2012, 490(7418): 61-70.
|
| [9] |
Asaga S, Kuo C, Nguyen T, et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer[J]. Clin Chem, 2011, 57(1): 84-91.
|
| [10] |
Levine B, Kroemer G. Autophagy in the pathogenesis of disease[J]. Cell, 2008, 132(1): 27-42.
|
| [11] |
Levine B, Kroemer G. Autophagy in aging, disease and death: the true identity of a cell death impostor[J]. Cell Death Differ, 2009, 16(1): 1-2.
|
| [12] |
Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy[J], Nat Cell Biol, 2010, 12(9): 814-822.
|
| [13] |
Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion[J]. Nature, 2008, 451(7182): 1069-1075.
|
| [14] |
Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response[J]. Mol Cell, 2010, 40(2): 280-293.
|
| [15] |
He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy[J]. Annu Rev Genet, 2009, 43: 67-93.
|
| [16] |
Yang S, Wang X, Contino G, et al. Pancreatic cancers require autophagy for tumor growth[J]. Genes Dev, 2011, 25(7): 717-729.
|
| [17] |
Joshi S, Kumar S, Ponnusamy MP, et al. Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival[J]. Oncogene, 2016, 35(45): 5882-5892.
|
| [18] |
Liu W, Yu G, Yu W, et al. Autophagy inhibits apoptosis induced by agrocybe aegerita lectin in hepatocellular carcinoma[J]．Anticancer Agents Med Chem, 2017, 17(2): 221-229.
|
| [19] |
Liu YL, Yang PM, Shun CT, et al. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma[J]. Autophagy, 2010, 6(8): 1057-1065.
|
| [20] |
Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab [J]. PLoS One, 2009, 4(7): e6251.
|
| [21] |
Kuo PL, Hsu YL, Cho CY. Plumbagin induces G(2)-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells[J]. Mol Cancer Ther, 2006, 5(12): 3209-3221.
|
| [22] |
Sinha S, Roy S, Reddy BS, et al. A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis[J]. Mol Cancer Res, 2011, 9(3): 364-374.
|
| [23] |
陈莎. IBP抑制自噬在乳腺癌增殖转移中的作用及其机制研究[D]. 重庆：第三军医大学，2013.
|
| [24] |
原红军，吴爱国，王梦川，等. 正常和低氧环境下转染beclin-1对乳腺癌细胞BT-549的抑制作用[J/CD]. 中华乳腺病杂志(电子版)，2012, 6(4)：383-393.
|
| [25] |
Hamurcu Z, Delibai N, Geçene S, et al. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/Src signaling in triple negative breast cancer cells [J]. J Cancer Res Clin Oncol, 2018, 144(3): 415-430.
|
| [26] |
韩起．分子伴侣自噬(CMA)在乳腺癌增殖转移中的作用及其机制研究[D]．重庆：第三军医大学，2014.
|
| [27] |
Wen J, Yeo S, Wang C, et al. Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis[J]. Breast Cancer Res Treat, 2015, 149(3): 619-629.
|
| [28] |
Huck B, Duss S, Hausser A, et al. Elevated protein kinase D3 (PKD3) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation[J]. J Biol Chem, 2014, 289(6): 3138-3147.
|
| [29] |
Wang M, Zhang J, Huang Y, et al. Cancer-associated fibroblasts autophagy enhances progression of triple-negative breast cancer cells [J]. Med Sci Monit, 2017, 23: 3904-3912.
|
| [30] |
易贺庆. miR-199a-5p在电离辐射诱导乳腺癌细胞自噬中作用的研究[D]. 长春：吉林大学，2013.
|
| [31] |
孙权权. miR-200c靶向UBQLN1调节自噬及乳腺癌的辐射抵抗[D]. 广州：南方医科大学，2014.
|
| [32] |
Zhou ZR, Yang ZZ, Wang SJ, et al. The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy[J]. Acta Pharmacol Sin, 2017, 38(4): 513-523.
|
| [33] |
Zhang L, Shamaladevi N, Jayaprakasha GK, et al. Polyphenol-rich extract of Pimenta dioica berries (Allspice) kills breast cancer cells by autophagy and delays growth of triple negative breast cancer in athymic mice[J]. Oncotarget, 2015, 6(18): 16 379-16 395.
|
| [34] |
Wang S, Chen XA, Hu J, et al. ATF4 gene network mediates cellular response to the anticancer PAD inhibitor YW3-56 in triple-negative breast cancer cells [J]. Mol Cancer Ther, 2015, 14(4): 877-888.
|
| [35] |
Al Dhaheri Y, Attoub S, Ramadan G, et al. Carnosol induces ROS-mediated beclin1-independent autophagy and apoptosis in triple negative breast cancer[J]. PLoS One, 2014, 9(10): e109630.
|
| [36] |
Zhang L, Guo M, Li J, et al. Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer[J]. Mol Biosyst, 2015, 11(11): 2860-2866.
|
| [37] |
全军利，贺文兴，吴斯敏，等. 隐丹参酮对乳腺癌MDA-MB-231细胞自噬和侵袭迁移的影响[J]．广西医科大学学报，2015, 32(1)：23-26.
|
| [38] |
Li HC, Xia ZH, Chen YF, et al. Cantharidin inhibits the growth of triple-negative breast cancer cells by suppressing autophagy and inducing apoptosis in vitro and in vivo[J]. Cell Physiol Biochem, 2017, 43(5): 1829-1840.
|
| [39] |
Braicu C, Pileczki V, Pop L, et al. Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model[J]. PLoS One, 2015, 10(4): e0120936.
|
| [40] |
周静，李国兵，郑怡，等. 莲心碱对乳腺癌细胞MDA-MB-231自噬功能的影响[J]. 第三军医大学学报，2015, 37(7)：629-633.
|
| [41] |
Wang Z, Shi X, Li Y, et al. Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells[J]. Cell Death Dis, 2014, 5: e1563.
|
| [42] |
Aydinlik S, Erkisa M, Cevatemre B, et al. Enhanced cytotoxic activity of doxorubicin through the inhibition of autophagy in triple negative breast cancer cell line[J]. Biochim Biophys Acta, 2017, 1861(2): 49-57.
|
| [43] |
陈莎，韩起，王旭辉，等. 调节自噬对乳腺癌细胞紫杉醇耐药性影响的实验研究[J]. 时珍国医国药，2015, 37(7)：629-663.
|
| [44] |
苏冰. 下调MTDH基因抑制表柔比星诱导的三阴性乳腺癌细胞自噬现象的研究[D]. 大连：大连医科大学，2014.
|
| [45] |
Chen M, He M, Song Y, et al. The cytoprotective role of gemcitabine-induced autophagy associated with apoptosis inhibition in triple-negative MDA-MB-231 breast cancer cells[J]. Int J Mol Med, 2014, 34(1): 276-282.
|
| [46] |
Lefort S, Joffre C, Kieffer Y, et al. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers[J]. Autophagy, 2014, 10(12): 2122-2142.
|
| [47] |
Park JH, Kim KP, Ko JJ, et al. PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy[J]. Biochem Biophys Res Commun, 2016, 477(2): 277-282.
|
| [48] |
Fan YX, Dai YZ, Wang XL, et al. MiR-18a upregulation enhances autophagy in triple negative cancer cells via inhibiting mTOR signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2016, 20(11): 2194-2200.
|
| [49] |
Vogel RI, Coughlin K, Scotti A, et al. Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells[J]. Oncotarget, 2015, 6(6): 4159-4170.
|
| [50] |
Lee WY, Hsu KF, Chiang TA, et al. Phellinus linteus extract induces autophagy and synergizes with 5-fluorouracil to inhibit breast cancer cell growth[J]. Nutr Cancer, 2015, 67(2): 275-284.
|
| [51] |
Thomas S, Sharma N, Golden EB, et al. Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors[J]. Cancer Lett, 2012, 325(1): 63-71.
|
| [52] |
Rao R, Balusu R, Fiskus W, et al. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells[J]. Mol Cancer Ther, 2012, 11(4): 973-983.
|
| [53] |
刘兆芸，贺科文，宋兴国，等. 自噬抑制剂可增强三阴性乳腺癌细胞系MDA-MB-468和MDA-MB-231对吉非替尼的敏感性[J]．中华肿瘤杂志，2016, 38(6)：417-424.
|
| [54] |
Zhao H, Yang M, Zhao J, et al. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer[J]. Med Oncol, 2013, 30(1): 475.
|
| [55] |
Choi J, Jung W, Koo JS. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer[J]. Histopathology, 2013, 62(2): 275-286.
|
| [56] |
Wang MC, Wu AG, Huang YZ, et al. Autophagic regulation of cell growth by altered expression of Beclin 1 in triple-negative breast cancer[J]. Int J Clin Exp Med, 2015, 8(5): 7049-7058.
|
| [57] |
Chittaranjan S, Bortnik S, Dragowska WH, et al. Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer[J]. Clin Cancer Res, 2014, 20(12): 3159-3173.
|
| [58] |
郑临海，吴爱国，范旭龙，等. 短程低氧条件下乳腺癌BT549细胞表达beclin 1基因对上皮间质转化的影响[J/CD]. 中华乳腺病杂志(电子版), 2014, 8(1)：13-21.
|